High dividend stocks are a great way to provide income from your portfolio. But more importantly, good high dividend stocks provide stability in times of trouble.
Top Specialty Retail Stocks To Buy For 2015: Intrexon Corp (XON)
Intrexon Corporation, incorporated on April 19, 2004, is engaged in the business of synthetic biology. Using the Company�� suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (DNA) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences. Its technologies include the UltraVector gene design and fabrication platform; Cell Systems Informatics; LEAP-cell identification and selection, and mAbLogix-antibody discovery.
The Company�� LEAP technology facilitates the automated identification of an individual cell with the highest levels of expression, quality and potency from a population of over 100,000 cells. Its mAbLogix platform complements UltraVector with a library of human antibodies that exceeds 500 million. By immortalizing human tonsils, which consists of lymphatic tissue containing B-cells, its mAbLogix platform creates a B-cell library that can generate antibodies against an almost infinite number of new antigens.
The UltraVector gene design and fabrication platform
The Company�� gene program design platform, which it refer to as UltraVector, is an integrated suite of tools comprising advanced DNA construction technology and components, cellular and protein engineering tools, computational models and statistical methods which facilitate the rapid design, build and testing of complex systems. The UltraVector platform allows the Company to translate gene programs into standard components that can be designed, manufactured and tested in an automated format. This technology enables it to engineer at the cellular level from biological sources.
UltraVector DNA design is computer-automated and ! utilizes a set of defined construction rules to assemble components that are stored in its DNA library. In addition to the number of gene components in its UltraVector library, it is designing and creating enzymatic and regulatory components that provide control over genome integration and gene regulation. Its RheoSwitch Therapeutic System is a three-component transcriptional regulator that provides inducible gene expression. The RheoSwitch Therapeutic System provides the ability to not only express proteins/enzymes of interest, but also the ability to control the level and timing of expression to achieve a biological outcome. Other ongoing programs include its Attsite recombinases, which mediate predictable gene exchange into host cells thereby eliminating many of the difficulties seen with traditional gene insertion.
Cell Systems Informatics
The Company�� Cell systems informatics permits design, as well as testing and learning about new gene targets or product pathways. Its bioinformatics software and database systems for mapping cellular pathways when combined with its genome-scale modeling and experimental data, including, gene expression profiling and protein engineering, enable the Company to optimize selection and development of gene programs and cellular systems for its collaborators. Its computational modeling and simulation platform enables the development of predictive computer models of organisms, from microbes to humans. This platform builds virtual cells from their basic molecular components, and can simulate the activity of the cell�� complete reaction network.
The Company is designing proteins with post-translational modifications. It is also working to develop enzyme inhibitors and fusion proteins for a variety of applications in human and animal therapeutics. Its protein engineering may utilize one or more of its technologies to obtain catalysis activitiesits component library, the generation of component variants sequence, evolutionary analy! sis and s! tructure-based sequence alignment, computer-aided drug discovery, de novo, or synthesized or generated, and comparative protein modeling, molecular dynamics simulation and free energy analysis, antibody design and humanization, antigenicity prediction, protein pharmacokinetics optimization, and/or in silico support of enzyme engineeringand quantitative structure-function relationships with machine learning algorithms to optimize, facilitate and prioritize protein variant libraries for the advancement of its collaborators.
LEAP-cell identification and selection
The Company�� Laser-Enabled Analysis and Processing technology (LEAP), is an instrument that merges semiconductor manufacturing technologies for cell processing applications to provide high levels of control and scale to cell purification and stem cell culture management. The LEAP platform can identify and purify cells of interest from large libraries of cells created by its UltraVector and bioinformatics technologies using a laser-based purification process, thereby providing a mechanism of testing the degree of protein expression in genetically modified cells, as well as means to learn from the genetic building process.
mAbLogix- antibody discovery
The Company�� mAbLogix antibody discovery platform, or mAbLogix platform, enables production of B-cell libraries for discovery of antibodies. The mAbLogix platform permits antigen targeting using fully human monoclonal and polyclonal antibodies. Its mAbLogix antibody discovery process consists of two major activities: the build of human B-cell libraries expressing a large number of antibodies, and the testing of these libraries based on an analysis of B-cells that express antibodies in response to a chosen antigen.
The Company competes with AbD SeroTec, Alexion Pharmaceuticals, Inc., XOMA Corporation, Genmab US, Inc., MorphoSys AG, NovImmune SA, Societe Des Systemes Biologiques, Adimab, LLC, ProMab Biotechnologies, Inc., Abpro, Inc.,! AIIM The! rapeutics and Open Monoclonal Technology, Inc.
Advisors' Opinion:- [By John Udovich]
Bubble talk, biotech IPO setbacks plus news�about small cap biotechs like Intrexon Corp (NYSE: XON) and TNI BioTech (OTCMKTS: TNIB) have dominated biotech news this week or in recent weeks. Just consider the following news:
5 Best High Dividend Stocks For 2014: Industrias Bachoco S.A. de C.V. (IBA)
Industrias Bachoco, S.A.B. de C.V., through its subsidiaries, operates as a poultry producer in Mexico. It engages in breeding, processing, and marketing of poultry products, such as chicken and table eggs; and balanced animal feed comprising swine and other products. The company also offers turkey and value-added beef and pork products. It sells its products to wholesalers, retailers, supermarkets, rosticer Advisors' Opinion:
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Industrias Bachoco (NYSE: IBA ) , whose recent revenue and earnings are plotted below. - [By John Udovich]
Thanksgiving is around the corner�meaning investors might want to take a closer look at turkey stocks�like Hormel Foods Corporation (NYSE: HRL), Seaboard Corporation (NYSEMKT: SEB) and Industrias Bachoco, S.A.B. de C.V. (NYSE: IBA)���the last major�publicly traded turkey stocks available for investors. Moreover, the Wall Street Journal has pointed out that corn prices are the lowest in more than three years and fewer birds are in production as some producers cut back on their flocks this year due to weaker turkey commodity prices.�Feed prices, which make up about 70% of the cost of a turkey, had soared with the price of corn which hit the $8 a bushel level but a recent�bumper crop has sent corn prices plunging to about the $4 a bushel level.
5 Best High Dividend Stocks For 2014: Hurco Companies Inc. (HURC)
Hurco Companies, Inc., an industrial technology company, engages in the design, manufacture, and sale of computerized machine tools, computer control systems, and software products to companies in the metal working industry primarily in North America, Europe, and Asia. The company offers general purpose computerized machine tools, such as vertical machining centers/mills and turning centers/lathes. It also provides computer control systems and related software for press brake applications. In addition, the company produces and distributes software options, control upgrades, hardware accessories, and replacement parts for its machine tool product lines, as well as provides operator training and support services to its customers. Hurco Companies, Inc. offers its products to the precision tool, die, and mold manufacturers; independent metal parts manufacturers; and specialized production application or prototype departments within manufacturing operations. It serves aerospace , defense, medical equipment, energy, automotive/transportation, electronics, and computer industries. The company sells its products through independent agents and distributors in North America, Europe, and Asia, a swell as through direct sales personnel in Canada, China, France, Germany, Italy, Poland, Singapore, South Africa, Spain, the United Kingdom, and certain parts of the United States. Hurco Companies, Inc. was founded in 1968 and is headquartered in Indianapolis, Indiana.
Advisors' Opinion:- [By John Emerson]
Hardinge (HDNG) the Perfect Fit to the Investment Puzzle
Several years earlier I had started following the machine tool sector and I became quite familiar with Hardinge. Although I never invested in the stock (I had opted for Hurco), I had noted that Jeffrey Gendell had been purchasing shares the company. Hurco (HURC) had much higher margins and it was my belief that the superior quality of their computerized machine tools and their accompanying software were reflected in their earnings. Hurco also held a vastly superior balance sheet at the time I made my investment.
5 Best High Dividend Stocks For 2014: HFF Inc (HF)
HFF, Inc. is a provider of commercial real estate and capital markets services to both the users and providers of capital in the United States commercial real estate industry. It is a full-service commercial real estate financial intermediary in the United States. As of December 31, 2011, the Company operated out of 20 offices nationwide. During the year ended December 31, 2011, the Company advised on approximately $35.6 billion of completed commercial real estate transactions. The Company offers debt placement, investment sales, distressed debt and real estate owned advisory services, structured finance, private equity placement, investment banking services, loan sales and commercial loan servicing. In October 2011, the Company sold Las Olas City Centre. In March 2012, the Company sold 801 9th Street, NW, a 236,054 square-foot, Class A office building in Washington, D.C. In July 2013, the Company announced that it has closed the sale of Washington Harbour, a 557,961-square-foot, mixed-use project located along the Potomac River in Washington, D.C.'s Georgetown submarket. In September 2013, the Company announced that it has closed the sale of Greenway Plaza, a 4.4 million-square-foot, Class A office complex in Houston, Texas, and 777 Main, a 980,374-square-foot Class A office property in Fort Worth, Texas. In November 2013, HFF Inc closed the sale of The Granary. In November 2013, the Company�� subsidiary, Holliday Fenoglio Fowler, L.P. sold Avalon on the Sound East, a 588-unit, 39-story, Class A multi-housing tower in New Rochelle, New York. In December 2013, HFF Inc sold its Pacific Commons Shopping Center, an 865,783-square-foot center in Fremont. In January 2014, HFF Inc has closed the sale of 225 West Santa Clara, a 16-story, 349,318-square-foot, transit-oriented trophy office property in downtown San Jose, California. In January 2014, HFF, Inc. sold two Central Florida Publix-anchored retail properties in Orlando and suburban Tampa, and sold eight-property, fully leased industrial portfolio in! the Meadowlands submarket of New Jersey. In January 2014, HFF Inc closed the sale of 800 Madison, a 217-unit, Class A multi-housing community with ground floor retail in Hoboken, New Jersey.
Debt Placement Services
The Company offers its clients a range of debt instruments, including but not limited to, construction and construction/mini-permanent loans, adjustable and fixed rate mortgages, entity level debt, mezzanine debt, forward delivery loans, tax exempt financing and sale/leaseback financing. Its clients are owners of various types of property, including, but not limited to, office, retail, industrial, hotel, multi-housing, self-storage, assisted living, nursing homes, condominiums and condominium conversions, mixed-use properties and land. The Company�� clients range in size from individual entrepreneurs who own a single property to the large real estate funds and institutional property owners worldwide who invest globally, especially in the United States. Debt is or has been placed with capital funding sources, both domestic and foreign, including, but not limited to, life insurance companies, conduits, investment banks, commercial banks, thrifts, agency lenders, pension funds, pension fund advisors, real estate investment trusts (REITs), credit companies, opportunity funds and individual investors. In 2011, its transaction volume in debt placements was approximately $18.7 billion.
Investment Sales Services
The Company provides investment sales services to commercial real estate owners who are seeking to sell one or more properties or property interests. In 2011, it completed investment sales of approximately $12.6 billion.
Structured Finance and Private Equity Services
The Company offers an array of structured finance and private equity alternatives and solutions at both the property and ownership entity level. In 2011, it completed approximately $2 billion of structured finance and advisory services transactions.
Private Equity, Investment Banking and Advisory Services
The Company�� broker-dealer subsidiary, HFF Securities L.P. (HFF Securities), undertakes both discretionary and non-discretionary private equity raises, select property specific joint ventures and select investment banking activities for its clients. At December 31, 2011, it had $1.9 billion of active private equity discretionary fund transactions. Through HFF Securities, it offers its clients the ability to access the private equity markets for an identified commercial real estate asset and discretionary private equity funds, joint ventures, entity-level private placements and advisory services, as well as structured finance services. HFF Securities��services to its clients include joint ventures, private placements, advisory services, and marketing and fund-raising.
Loan Sales
The Company assists its clients to sell all or portions of their commercial real estate debt note portfolios, which can include performing, non-performing and distressed debt and/or real estate owned properties. It had consummated $2.3 billion in loan sales transactions in 2011.
Commercial Loan Servicing
The Company provides commercial loan servicing (primary and sub-servicing) for life insurance companies, Federal Home Loan Mortgage Corporation (Freddie Mac), Federal National Mortgage Association (Fannie Mae) through relationships with a range of delegated underwriting and servicing (DUS) lenders, commercial mortgage-backed securities (CMBS) originators, mortgage REITS and debt funds, groups that purchase performing and/or non-performing loans, as well as owners who sell commercial real estate subject to a purchase money mortgage. During 2011, it had approximately 35 correspondent lender relationships with life insurers.
The Company competes with CBRE Capital Markets, Cushman & Wakefield, Eastdil Secured, Jones Lang LaSalle, Northmarq Capital and Berkadia.
Advisors' Opinion:- [By Hilary Kramer]
2. Real Estate Investment Trusts (REITs) The REIT is another alternative vehicle that's gone mainstream in recent years. Hundreds of broad-based and specialized real estate companies and ETFs are available, and after a correction a few months ago, many are on the cheap side. Like any other alternative, this should be a seasoning for your portfolio and not the sauce itself. For most retail investors, a stake in an indexed fund like the SPDR Dow Jones REIT (NYSE: RWR) should be more than adequate, or look into the companies that provide services to the REIT industry like HFF (NYSE: HF) and Jones Lang LaSalle (NYSE: JLL).
No comments:
Post a Comment